Alpha-Glucosidase Inhibitors: Side Effects, Warnings, and Hypoglycemia Safety

Written by: Dr. Albana Greca, MD, MMedSc

Medically reviewed by: Dr. Ruden Cakoni, MD, Endocrinologist

Last medically reviewed: September 2026

If you live with diabetes, it is understandable to want a simple answer to the question, “What blood sugar should I aim for?”

For many adults, there are well-established treatment targets. However, I always remind my patients that these are general goals, not one-size-fits-all rules. Your safest target depends on your age, type and duration of diabetes, medicines, risk of hypoglycemia, pregnancy status, kidney or heart disease, and overall health.

The goal is not to keep glucose at one perfect number all day. It is to remain within a safe range as consistently as possible while avoiding prolonged high blood sugar and unnecessary low blood sugar.

Quick Answer: Common Blood Glucose Targets

For many nonpregnant adults with diabetes, commonly used treatment goals are:

  • Before meals: 80–130 mg/dL (4.4–7.2 mmol/L)
  • Peak after meals: below 180 mg/dL (below 10.0 mmol/L), measured 1–2 hours after the beginning of the meal
  • A1C: below 7% (below 53 mmol/mol), when this can be achieved safely
Measurement Common target What it means
Before meals 80–130 mg/dL
(4.4–7.2 mmol/L)		 A common premeal target for many nonpregnant adults
Peak after meals Below 180 mg/dL
(below 10.0 mmol/L)		 Usually assessed 1–2 hours after the beginning of the meal
A1C Below 7%
(below 53 mmol/mol)		 A common longer-term goal when it can be reached safely
Important: These are treatment targets for many adults who already have diabetes. They are different from the laboratory thresholds used to diagnose diabetes or prediabetes.

What Does “Acceptable Blood Glucose” Mean?

An acceptable blood glucose level is not necessarily the same as a “normal” glucose level in someone without diabetes.

When we set a diabetes target, we balance two priorities: keeping glucose low enough to reduce the risk of long-term complications while avoiding hypoglycemia and treatment that is too aggressive for the individual patient.

A single blood glucose reading does not provide a complete picture of diabetes control. In clinical practice, I consider the broader pattern, including fasting and premeal glucose levels, post-meal readings when appropriate, A1C, episodes of hypoglycemia, symptoms, current medications, and, when available, continuous glucose monitoring (CGM) data. These measures should also be interpreted in the context of established blood glucose and A1C ranges for normal glucose, prediabetes, and diabetes.

Acceptable Blood Glucose Before Meals

For many nonpregnant adults with diabetes, a common target before meals is 80–130 mg/dL (4.4–7.2 mmol/L).

This gives us useful information about your baseline glucose before food begins to raise it. If most of your premeal readings are within your agreed target, that is encouraging, but they should still be interpreted together with your post-meal pattern, A1C, low-glucose episodes and overall treatment plan.

A reading of 80 mg/dL is not hypoglycemia. It is near the lower end of the usual premeal target. Hypoglycemia is generally defined as glucose below 70 mg/dL.

If fasting or premeal readings are repeatedly above your personal target, possible contributors include overnight glucose production, meal or medication timing, illness, poor sleep, stress and changes in physical activity. A pattern over several days is more informative than one isolated morning reading.

If morning glucose is your main concern, see our guide to fasting blood sugar levels.

Acceptable Blood Glucose After Meals

For many adults with diabetes, a common target is a peak post-meal glucose below 180 mg/dL (10.0 mmol/L).

When post-meal glucose is being assessed, it is generally measured 1–2 hours after the beginning of the meal. The timing matters because this period is intended to capture glucose near its post-meal peak.

One reading slightly above 180 mg/dL does not necessarily mean your treatment is failing. A larger meal, more carbohydrate than usual, illness, stress, poor sleep or reduced activity can all affect the result. More important questions are whether higher readings occur frequently, remain elevated for a long time, or appear alongside an A1C or CGM pattern showing excessive glucose exposure.

Do not confuse a treatment target with a diagnostic test. The below-180 mg/dL target is used in diabetes management. The 140 and 200 mg/dL diagnostic thresholds apply to a standardized two-hour 75-g oral glucose tolerance test, not to an ordinary meal eaten at home.

Because blood glucose changes throughout the day, the timing of a measurement matters, particularly when interpreting blood sugar levels after eating.

How Does A1C Fit With Daily Blood Sugar Targets?

Daily readings show what your blood sugar is doing at a particular moment. A1C provides a broader view of glucose exposure over the previous two to three months, with more recent weeks contributing more to the result.

For many nonpregnant adults with diabetes, a common A1C goal is below 7% (53 mmol/mol) when it can be achieved safely. Some people may benefit from a lower goal. Others need a less stringent goal because hypoglycemia, frailty, serious comorbidities, cognitive or functional limitations, or treatment burden makes tighter control less safe.

I would not interpret A1C in isolation. Two people can have the same A1C while experiencing very different patterns of highs and lows.

Learn more in A1C vs Blood Sugar, or use our HbA1c to Average Glucose Calculator.

What If I Use a Continuous Glucose Monitor?

A continuous glucose monitor, or CGM, helps us look beyond individual fingerstick readings. It shows how much time glucose spends within, above and below the target range.

CGM metric Common goal for many adults
Time in range: 70–180 mg/dL More than 70% of the time
Time below 70 mg/dL Less than 4% of the time
Time below 54 mg/dL Less than 1% of the time
Time above 180 mg/dL Less than 25% of the time

CGM goals also need to be individualized. Some older adults with complex health problems, for example, may need more permissive goals to reduce the risk of hypoglycemia.

What About Bedtime Blood Sugar?

There is no single bedtime glucose target appropriate for every adult with diabetes. Bedtime goals depend on insulin use, risk of overnight hypoglycemia, age, other medical conditions, recent exercise, meal timing and the treatment plan you follow.

If you use insulin or medicines that can cause hypoglycemia, your clinician may give you a specific bedtime target. Follow that individualized plan rather than relying on a universal bedtime number from the internet.

What Is Considered Low Blood Sugar?

For people with diabetes, glucose below 70 mg/dL (3.9 mmol/L) is considered hypoglycemia and should be taken seriously. A level below 54 mg/dL (3.0 mmol/L) is more clinically significant.

Symptoms may include shakiness, sweating, hunger, palpitations, dizziness, weakness, irritability, confusion or difficulty concentrating. If you have a hypoglycemia treatment plan, follow it promptly. Frequent low readings require medical review because medication dose, meal timing or activity may need adjustment.

Get emergency help if the person becomes unconscious, has a seizure, cannot swallow safely, is severely confused, or needs another person to help them recover.

Why Your Personal Target May Be Different

I would not give exactly the same glucose goal to every patient. Your targets may need to be individualized if you:

  • are pregnant or planning pregnancy;
  • are a child or adolescent;
  • are an older adult;
  • have frequent or severe hypoglycemia;
  • have impaired awareness of low blood sugar;
  • have significant kidney, heart, liver or other medical disease;
  • have cognitive or functional limitations;
  • have lived with diabetes for many years; or
  • use insulin or medicines that increase hypoglycemia risk.

An older adult who is otherwise healthy may still have relatively tight glucose goals. Someone with frailty, several serious illnesses or recurrent hypoglycemia may need more relaxed targets because preventing low blood sugar becomes the greater priority.

Different blood sugar targets for children, older adults, pregnancy, insulin users and people at risk of hypoglycemia
Blood sugar targets are individualized according to age, pregnancy, medications, hypoglycemia risk and overall health.

What Can Affect Your Blood Glucose Readings?

Even when your treatment plan has not changed, glucose can vary from day to day. Common influences include:

  • meal size and carbohydrate content;
  • physical activity;
  • stress and sleep;
  • infection, illness or pain;
  • dehydration or alcohol;
  • hormonal changes;
  • medication timing;
  • missed insulin or diabetes medicine; and
  • corticosteroids and some other medicines.

This is why I encourage patients to look for patterns rather than reacting strongly to one unusual result.

Factors affecting blood glucose readings, including food, activity, stress, sleep, illness and medicines
Meals, activity, sleep, stress, illness and medications can all change glucose readings.

How to Keep Blood Glucose Closer to Your Target

Keeping glucose in range does not require perfect numbers every day. The practical goal is to make the overall pattern safer and more consistent. Depending on your treatment plan, helpful steps may include:

  • taking insulin or diabetes medicine exactly as prescribed;
  • checking glucose at the times recommended by your healthcare team;
  • keeping carbohydrate portions reasonably consistent when this is part of your plan;
  • choosing meals with vegetables, protein, fiber and appropriate carbohydrate portions;
  • being physically active regularly;
  • reviewing repeated highs or lows instead of changing medication on your own;
  • paying attention to sleep, illness, stress and hydration; and
  • bringing your glucose log or CGM report to medical appointments.

Do not change insulin or medication doses because of one unusual result unless your healthcare professional has given you a specific adjustment plan.

Practical ways to help keep blood glucose within the target range
Consistent medication use, balanced meals, activity and review of glucose patterns can support safer diabetes control.

Dr. Albana’s Perspective

When a patient asks whether a blood sugar number is “acceptable,” I first ask when it was measured and what target we agreed on for that person.

A premeal glucose of 125 mg/dL may be within the usual target for many adults with diabetes. The same number means something different if we are discussing a fasting laboratory test used to screen a person who has not been diagnosed with diabetes.

I also do not judge diabetes control from one good reading or one bad reading. I want to know whether most values are reasonably close to target, whether there are repeated highs, whether low glucose is occurring, and whether the A1C or CGM report tells the same story.

The best target is not the lowest number you can achieve. It is the range that offers meaningful long-term protection while remaining safe and realistic for your health and treatment.

When Should You Contact Your Doctor?

Contact your healthcare team if:

  • glucose is repeatedly above your agreed target;
  • you have repeated readings below 70 mg/dL;
  • you experience nighttime hypoglycemia;
  • your A1C is rising despite apparently reasonable daily readings;
  • your CGM shows frequent highs or lows;
  • you are ill and glucose becomes difficult to control;
  • you are unsure whether medication or insulin needs adjustment; or
  • your target may no longer be appropriate because of pregnancy, aging or a new medical condition.
Seek urgent medical care for severe hypoglycemia, loss of consciousness, seizures, repeated vomiting, severe dehydration, marked drowsiness, difficulty breathing, fruity-smelling breath, or symptoms suggesting diabetic ketoacidosis or another hyperglycemic crisis.

Related Questions

Is 130 mg/dL acceptable for someone with diabetes?

It depends on when it was measured. For many nonpregnant adults, 130 mg/dL is at the upper end of the common premeal target. After a meal, it may also be within an acceptable range, but your individual target may differ.

Is 180 mg/dL after eating acceptable?

For many adults with diabetes, the common goal is a peak post-meal glucose below 180 mg/dL, assessed 1–2 hours after the beginning of the meal. Frequent readings at or above this level should be reviewed as a pattern.

Is 70 mg/dL acceptable?

Seventy mg/dL is the threshold at which we become concerned about hypoglycemia. A reading below 70 mg/dL should be treated according to your diabetes plan, and repeated lows should be discussed with your healthcare team.

Should everyone with diabetes have the same glucose target?

No. Age, pregnancy, medications, hypoglycemia risk, kidney or heart disease, functional status and other health conditions can all affect the safest goal.

What should my blood sugar be at bedtime?

There is no universal bedtime target for every adult with diabetes. Your bedtime goal should reflect your treatment plan, especially if you use insulin or are at risk of overnight hypoglycemia.

Is A1C below 7% right for everyone?

No. Below 7% is a common goal for many nonpregnant adults, but some people may benefit from a lower goal and others need a less stringent one for safety.

Related Tools and Calculators

Related Resources

Final Key Message

For many nonpregnant adults with diabetes, common treatment goals are 80–130 mg/dL before meals, below 180 mg/dL at the peak after meals, and A1C below 7% when these goals can be achieved safely.

If you use CGM, spending more than 70% of the time between 70 and 180 mg/dL is a common goal for many adults, while time below 70 mg/dL should remain limited.

Most importantly, your target should fit you. A safe plan balances glucose control with your risk of hypoglycemia, medications, age, other medical conditions and daily life. I would rather see a patient follow a realistic, individualized target safely and consistently than chase a “perfect” number that creates unnecessary risk.

References

  1. American Diabetes Association Professional Practice Committee. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl. 1).
  2. American Diabetes Association Professional Practice Committee. Older Adults: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl. 1).
  3. American Diabetes Association. Checking Your Blood Sugar.
  4. National Institute of Diabetes and Digestive and Kidney Diseases. Managing Diabetes. National Institutes of Health.

Medical disclaimer: This information is for general education and does not replace professional medical advice, diagnosis or treatment. Follow the glucose targets and treatment plan recommended by your healthcare professional. Do not change insulin or diabetes medication doses without appropriate medical guidance.

Written by: Dr. Albana Greca, MD, MMedSc, Family Physician

Medically reviewed by: Dr. Ruden Cakoni, MD, Endocrinologist

Last medically reviewed: July 2026

Quick answer

Alpha-glucosidase inhibitors—mainly acarbose and miglitol in the United States—slow the digestion of carbohydrates and reduce the rise in glucose after meals. Their most common side effects are gas, abdominal discomfort, bloating, soft stools, and diarrhea. They rarely cause hypoglycemia when used alone, but low glucose can occur when they are combined with insulin or a sulfonylurea. If that happens, use glucose/dextrose rather than table sugar, because these medicines delay the breakdown of sucrose.

What are alpha-glucosidase inhibitors?

Alpha-glucosidase inhibitors are oral medicines used with diet and physical activity to improve glucose management in adults with type 2 diabetes. Acarbose and miglitol are the two drugs in this class listed in current U.S. guidance. Voglibose is available in some other countries.

These medicines work mainly in the small intestine. They inhibit enzymes that break complex carbohydrates and sucrose into absorbable glucose and other simple sugars. Carbohydrate digestion therefore happens more slowly, which can reduce the glucose rise after a meal. They do not simply “block all glucose absorption.”

Because their effect depends on the meal, they are generally taken with the first bite of each main meal. Follow the exact schedule on your prescription; do not add a missed dose after the meal unless your pharmacist or prescriber has told you what to do.

Place in treatment: These medicines are not automatically a universal “third-line” treatment. Modern type 2 diabetes therapy is chosen according to glucose and weight goals, heart and kidney disease, liver health, hypoglycemia risk, side effects, cost, availability, and personal preferences.

Common alpha-glucosidase inhibitor side effects

Side effectWhy it happensWhat you should know
Gas and flatulenceMore undigested carbohydrate reaches the lower intestine, where bacteria ferment it.This is the most characteristic side effect. It is often strongest during the first weeks and may decrease with time.
Bloating or abdominal discomfortGas formation and delayed carbohydrate digestion can stretch or irritate the bowel.Report symptoms that are severe, persistent, or accompanied by marked swelling, vomiting, constipation, or inability to pass gas.
Soft stools or diarrheaUnabsorbed carbohydrates draw water into the intestine and undergo fermentation.Diarrhea often improves, but persistent diarrhea can cause dehydration and may require dose review or stopping the medicine.
Nausea or altered bowel patternThe gastrointestinal tract is adjusting to slower carbohydrate digestion.Do not treat persistent symptoms by drastically removing carbohydrates without discussing nutrition and medication with your care team.

Gastrointestinal effects are dose-related. A prescriber may begin with a low dose and increase it gradually according to tolerance and glucose response. Do not change the dose yourself. Eating more carbohydrate than recommended can intensify intestinal symptoms, but a balanced eating plan is still important.

alpha glucosidase inhibitors safety basics in

Can acarbose or miglitol cause hypoglycemia?

When used alone, alpha-glucosidase inhibitors should not normally cause hypoglycemia because they do not stimulate the pancreas to release insulin. Risk rises when they are used with insulin or an insulin-releasing medicine such as a sulfonylurea.

If glucose is below 70 mg/dL (3.9 mmol/L), follow your personal hypoglycemia plan and use glucose/dextrose.

Check the ingredient on glucose tablets or gel. It should say glucose, dextrose, or D-glucose. Table sugar is sucrose, and alpha-glucosidase inhibitors delay its breakdown, so it may correct hypoglycemia too slowly. Honey, candy, sugary syrup, or products relying mainly on sucrose are not the preferred emergency treatment while taking these medicines.

Recheck glucose according to your treatment plan. If the person cannot swallow safely, is unconscious, or has a seizure, do not give food or drink by mouth. Use prescribed glucagon if available and call emergency services. Severe hypoglycemia may require intravenous glucose or glucagon.

Less common but serious side effects

Liver-test abnormalities with acarbose

Acarbose can cause dose-related elevations in liver enzymes. Most reported trial elevations were asymptomatic and reversible, but rare serious liver reactions have been reported. This does not mean acarbose inevitably “damages the liver.” It means appropriate selection, monitoring, and attention to symptoms are important.

The current U.S. acarbose label recommends checking serum transaminases every three months during the first year and periodically afterward, particularly because higher doses may increase the risk. Acarbose is contraindicated in cirrhosis. Miglitol is not metabolized in the same way and has different hepatic considerations.

Rare intestinal complications

Rare postmarketing reports include ileus or partial ileus and pneumatosis cystoides intestinalis, a condition involving gas-filled cysts in the intestinal wall. Seek medical care for severe or persistent abdominal pain or swelling, repeated vomiting, inability to pass stool or gas, rectal bleeding, or mucus discharge.

Allergic reactions

Rash and hypersensitivity reactions can occur. Emergency help is needed for facial or throat swelling, difficulty breathing, or a rapidly spreading severe rash.

Contact a clinician promptly for:

  • yellow skin or eyes, dark urine, pale stools, severe fatigue, persistent nausea, or right-upper abdominal pain
  • severe abdominal pain, marked distention, vomiting, rectal bleeding, or inability to pass stool or gas
  • persistent diarrhea, dehydration, or inability to eat and drink normally
  • recurrent hypoglycemia when combined with insulin or a sulfonylurea

Who should not take alpha-glucosidase inhibitors?

Acarbose and miglitol are contraindicated in diabetic ketoacidosis and in people with certain significant intestinal conditions, including inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, predisposition to obstruction, marked digestion or absorption disorders, or a condition that may worsen with increased intestinal gas.

Acarbose is also contraindicated in cirrhosis. Kidney function requires careful review:

  • The acarbose label does not recommend treatment when significant renal dysfunction is present because long-term study data are lacking and drug exposure rises.
  • Miglitol is primarily eliminated through the kidneys and is not recommended when creatinine clearance is below 25 mL/min; the label also notes limited long-term data in significant renal dysfunction.

Do not decide suitability from one creatinine number alone. Kidney assessment today commonly uses estimated glomerular filtration rate or creatinine clearance together with the full clinical picture. Your prescriber should review kidney and liver history, bowel disease, pregnancy or breastfeeding, and all medicines and supplements.

How to use these medicines more safely

  1. Take the dose with the first bite of a main meal unless your prescription says otherwise.
  2. Follow gradual titration instructions. Increasing too quickly may worsen gas, bloating, and diarrhea.
  3. Keep glucose/dextrose available if you use insulin or a sulfonylurea.
  4. Know your combination medicines. Ask which of your tablets or injections can cause hypoglycemia.
  5. Complete requested laboratory monitoring, including kidney function and liver tests for acarbose.
  6. Report persistent gastrointestinal symptoms rather than silently stopping and restarting the medicine.
  7. Review interactions. Acarbose may affect digoxin exposure, while intestinal adsorbents such as charcoal and digestive-enzyme products may reduce its effect.
  8. Never replace prescribed treatment with a “natural alternative.” Some supplements can lower glucose, interact with medicines, or cause their own liver, kidney, or gastrointestinal problems.

Related questions

Why does acarbose cause so much gas?

Because carbohydrate digestion is delayed, more carbohydrate reaches bacteria in the lower intestine. Fermentation produces gas. Symptoms may improve with gradual dose titration and continued use, but severe or persistent symptoms need review.

Can I treat a low with fruit juice while taking acarbose?

The safest predictable choice is a product containing glucose or dextrose. Juice composition varies and may rely partly on sucrose, whose breakdown is delayed. Follow the specific hypoglycemia plan from your diabetes team.

Should I stop acarbose if I have diarrhea?

Do not make a permanent change without contacting your prescriber unless you have been given specific sick-day instructions. Mild symptoms may improve, but severe diarrhea, dehydration, bleeding, vomiting, or significant abdominal swelling needs prompt care.

Are alpha-glucosidase inhibitors bad for the liver?

Acarbose can raise liver enzymes and has rare reports of serious liver reactions, so monitoring is important. Liver injury is not inevitable. Acarbose should not be used in cirrhosis.

Are acarbose and miglitol first-, second-, or third-line medicines?

There is no universal position that fits every patient. Modern treatment selection is individualized according to glucose goals, other medical conditions, side effects, hypoglycemia risk, cost, and availability.

Related Beating Diabetes resources

References

  1. DailyMed. Acarbose Tablets—U.S. Prescribing Information.
  2. DailyMed. Miglitol Tablets—U.S. Prescribing Information.
  3. American Diabetes Association. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026.